APA (7th ed.) Citation

Y, C., V, R., S, T., A, B., C, M., M, S., . . . LP, L. (2025). Clinical Significance of Immune Deposits and Complement System Activation in FSGS: Findings from the Cure Glomerulonephropathy Network Study. Kidney360, 6(8), 1384. https://doi.org/10.34067/KID.0000000787

Chicago Style (17th ed.) Citation

Y, Caliskan, Royal V, Troyanov S, Bonnefoy A, Merlen C, Schnitzler M, Edwards JC, Lentine KL, and Laurin LP. "Clinical Significance of Immune Deposits and Complement System Activation in FSGS: Findings from the Cure Glomerulonephropathy Network Study." Kidney360 6, no. 8 (2025): 1384. https://doi.org/10.34067/KID.0000000787.

MLA (9th ed.) Citation

Y, Caliskan, et al. "Clinical Significance of Immune Deposits and Complement System Activation in FSGS: Findings from the Cure Glomerulonephropathy Network Study." Kidney360, vol. 6, no. 8, 2025, p. 1384, https://doi.org/10.34067/KID.0000000787.